Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients.
about
Activation of peripheral NMDA receptors contributes to human pain and rat afferent discharges evoked by injection of glutamate into the masseter muscle.Ketamine: 50 Years of Modulating the MindPeripheral pain mechanisms in chronic widespread pain.An increased response to experimental muscle pain is related to psychological status in women with chronic non-traumatic neck-shoulder pain.Dopamine and pain sensitivity: neither sulpiride nor acute phenylalanine and tyrosine depletion have effects on thermal pain sensations in healthy volunteersAltered neuromuscular control mechanisms of the trapezius muscle in fibromyalgia.Fibromyalgia: presentation and management with a focus on pharmacological treatment.Elevated insular glutamate in fibromyalgia is associated with experimental painTreatment of rat spinal cord injury with the neurotrophic factor albumin-oleic acid: translational application for paralysis, spasticity and pain.Central sensitization: implications for the diagnosis and treatment of pain.Novel pharmacotherapy for fibromyalgia.Fibromyalgia patients have reduced hippocampal volume compared with healthy controls.The role of quantitative sensory testing in the evaluation of musculoskeletal pain conditionsThe role of the central nervous system in the generation and maintenance of chronic pain in rheumatoid arthritis, osteoarthritis and fibromyalgiaDifferential effects of glutamate receptor antagonists on dorsal horn neurons responding to colorectal distension in a neonatal colon irritation rat modelLaser heat hyperalgesia is not a feature of non-specific chronic low back pain.Dysfunctional neurotransmitter systems in fibromyalgia, their role in central stress circuitry and pharmacological actions on these systemsCurrent trends in fibromyalgia research.Increased DNA fragmentation and ultrastructural changes in fibromyalgic muscle fibres.Incidence and predictors of secondary fibromyalgia in an early arthritis cohort.Perspectives on next steps in classification of oro-facial pain - Part 3: biomarkers of chronic oro-facial pain - from research to clinic.Fundamentals of muscle pain, referred pain, and deep tissue hyperalgesia.Mechanical and heat hyperalgesia highly predict clinical pain intensity in patients with chronic musculoskeletal pain syndromes.Evaluation of the efficacy of memantine in the treatment of fibromyalgia: study protocol for a doubled-blind randomized controlled trial with six-month follow-up.Genetic susceptibility and development of chronic non-malignant back pain.Descending facilitatory pathways from the RVM initiate and maintain bilateral hyperalgesia after muscle insultLow dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways.Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome.Acidic buffer induced muscle pain evokes referred pain and mechanical hyperalgesia in humans.Motor Cortex Excitability and BDNF Levels in Chronic Musculoskeletal Pain According to Structural PathologyTreatment options and patient perspectives in the management of fibromyalgia: future trends.Central mechanisms in the maintenance of chronic widespread noninflammatory muscle pain.Combined use of pregabalin and memantine in fibromyalgia syndrome treatment: a novel analgesic and neuroprotective strategy?Temporal summation of pain and ultrasound Doppler activity as predictors of treatment response in patients with rheumatoid arthritis: protocol for the Frederiksberg hospitals Rheumatoid Arthritis, pain assessment and Medical Evaluation (FRAME-cohortEmerging therapies for fibromyalgia: an update.Ketamine for the treatment of chronic non-cancer pain.NMDA receptor antagonists for the treatment of neuropathic pain.Neoteric pharmacotherapeutic targets in fibromyalgia.Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5-year retrospective analysis.Optimizing the early phase development of new analgesics by human pain biomarkers.
P2860
Q27863767-62EC3C81-65C3-4AA5-B872-29E1D3266ECAQ28077524-6F140A35-7DA1-4034-9F92-96172EE665E5Q30468936-578C6CC2-8234-4EDE-9711-9EFB0E5D3AA0Q31033422-64C12150-AA64-46AD-AB7B-06CE9894CEA0Q31143905-84E72625-5CDF-4480-9019-738F2F366B53Q33537382-7834D1E7-8FAD-4029-904B-58E094D92315Q33562399-0DCB1A5B-9563-42BB-9A83-FAB95A5BF0BDQ33684257-15408BE8-D03B-4D9D-9517-50920E2B93ACQ34064354-2F992B79-01F5-4D58-B84F-1E96701DDE41Q34144741-4CC1094E-66BD-4D8E-850B-8C3162736679Q34628135-F5C6695E-4D0A-44D7-8C76-A305B712DBEFQ35063775-1E86913C-E6CB-43F5-B2EB-75CAE52D4043Q35084026-AEF65487-4315-4D55-94A1-C243AFC76790Q35092990-6240F047-D5B6-4B15-A5A3-0984A21ADDC5Q35165975-ABF94716-DDD0-4CE3-908E-D063EB24210AQ35171291-6B851001-0F7C-461F-900B-19DCE4227058Q35374174-788714FA-8D25-4FA6-9AE8-84AC86D90020Q35548150-97EC6316-73BE-414D-8C43-277AE5124B62Q35553892-E81A0D9D-989C-47E4-B1A6-F513C16DFD97Q36369191-A36A9C0B-27C4-4301-B046-92AC0DEBE51BQ36469849-72B2A3A2-638E-4C62-A624-1F83DF56371BQ36602321-688A45DE-8C21-44D7-9C8C-3AE2821D8FACQ36637160-68DBB1CA-6037-44E0-A40F-3665F3B5063EQ36688619-A4A295CB-197B-4A10-AF4B-C11F4E89F86BQ36778980-67026E59-2290-44C6-B5EF-E652F699CC2CQ36844467-0A637037-4D4C-4AA2-A9B2-F7F8759839F8Q36860042-28EA66C1-D56C-43BA-87D3-08D856E04638Q36955343-F91A7567-9C3D-4620-981A-1A77CBDB97F5Q37036547-602B2188-E9AA-4BC4-89EF-400EA8A991A3Q37096934-0AC39141-A2D1-4C74-8F94-458627146006Q37106939-3336E0B6-DD89-43C8-A7B0-6A85133A0455Q37258911-2B1971D1-3ED9-4457-89BE-96D90F240999Q37337235-255C911A-13DE-410B-AD62-933C172C1672Q37517356-0A5235EF-C2D8-437B-A2C2-4B24EB7BB97BQ37756999-CF66E126-CBE0-453A-BB12-71EA03379049Q37786623-C0110DE8-C515-4D58-B05E-5F1BB280E4F2Q37806320-3D75239E-357B-4F48-B071-F77BEEA4E306Q37929796-610B1E49-41DB-4F24-AD62-9E75C86E4D0AQ37937069-09A5BA9F-ED45-44CC-BE19-2CFAF2E4D6A9Q37947690-4AB02B1E-10D1-44AB-B498-9A71E8E57394
P2860
Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Ketamine reduces muscle pain, ...... pain in fibromyalgia patients.
@ast
Ketamine reduces muscle pain, ...... pain in fibromyalgia patients.
@en
type
label
Ketamine reduces muscle pain, ...... pain in fibromyalgia patients.
@ast
Ketamine reduces muscle pain, ...... pain in fibromyalgia patients.
@en
prefLabel
Ketamine reduces muscle pain, ...... pain in fibromyalgia patients.
@ast
Ketamine reduces muscle pain, ...... pain in fibromyalgia patients.
@en
P2093
P1433
P1476
Ketamine reduces muscle pain, ...... pain in fibromyalgia patients.
@en
P2093
Aspegren Kendall S
Bengtsson M
Graven-Nielsen T
Henriksson KG
Sörensen J
P304
P356
10.1016/S0304-3959(99)00308-5
P407
P577
2000-04-01T00:00:00Z